about
Medication adherence in schizophreniaAssociation between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gainDefinitions and drivers of relapse in patients with schizophrenia: a systematic literature reviewAssessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study resultsRelapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial.Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia.Pharmacogenetics of antipsychotic-induced side effectsRisperidone long-acting injection: a review of its long term safety and efficacy.Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific surveyAdherence to medication in the community: audit cycle of interventions to improve the assessment of adherence.Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice.Effect of a system-oriented intervention on compliance problems in schizophrenia: a pragmatic controlled trial.Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).Management of antipsychotic treatment discontinuation and interruptions using model-based simulations.The meaning of pharmacological treatment for schizophrenic patients.Commentary: The Impact of Digital Technology on Psychological Treatments and Their Dissemination
P2860
Q26823655-5FFC9F85-EE72-4D2C-B743-1C9F86FC3BF2Q28266158-5127F8F3-0147-4398-976D-EE6BA5E4FCD4Q33589087-DF4C68B9-10FD-4750-A518-5D97C5C68D81Q34048194-2A1D6A2C-A1DF-4E2C-B657-E620289A9BBBQ34660553-766C6AC7-E077-4727-ACEC-62D3AB02FC2CQ35143555-CC1B4979-094B-4EA6-A79E-9DC4DA0A19A2Q35237129-C8149076-6C27-43C7-815F-1495BD8B25CDQ37062563-076D4CC4-CAE5-43EC-932E-DC505E2FDF13Q37104411-A24F4EC6-7757-499E-BC77-B72BFBF694D0Q37619620-DB3977A0-BA14-4574-89ED-36BB6E6EF73DQ37714573-ABC59B00-A7E3-414F-B09A-C122642C76C5Q40785183-14ED6C0B-E6FB-45EC-A388-8F175A5E8CE6Q41899147-9A0E124F-5A0B-4E67-867F-FFD727FBD824Q42149681-D7CFA107-03D3-4AE4-BCA5-77242CF51490Q42687191-D263C6F4-95E8-42EA-BD23-5ED1B6B3BF09Q58697962-128C9359-3B7B-4D9A-BEF8-CD0F7B01D43F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment adherence and long-term outcomes.
@en
type
label
Treatment adherence and long-term outcomes.
@en
prefLabel
Treatment adherence and long-term outcomes.
@en
P1433
P1476
Treatment adherence and long-term outcomes
@en
P2093
John M Kane
P356
10.1017/S1092852900026304
P433
10 Suppl 17
P577
2007-10-01T00:00:00Z